Sign In
Buy CRIS
$0.500
-0.0025 (-0.498%)
At Close: Jun 03, 2026
2 Names To Consider In A Heating Up Small-Cap Biotech Sector
12:00am, Wednesday, 27'th Nov 2019Edited Transcript of CRIS earnings conference call or presentation 5-Nov-19 1:30pm GMT
03:07am, Thursday, 21'st Nov 2019
Q3 2019 Curis Inc Earnings Call
Curis Abstracts for Fimepinostat and CA-4948 Accepted for Presentation at the 61st Annual Meeting of the American Society of Hematology
02:05pm, Wednesday, 06'th Nov 2019
LEXINGTON, Mass. , Nov. 6, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced t
Curis Reports Third Quarter 2019 Financial Results
12:00pm, Tuesday, 05'th Nov 2019
LEXINGTON, Mass., Nov. 5, 2019 /PRNewswire/ -- Curis, Inc. (CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported its financ
Curis Q3 EPS $(0.19) Up From $(0.22) YoY, Sales $2.856M Beat $2.4M Estimate
12:00am, Tuesday, 05'th Nov 2019/U P D A T E D -- Curis, Inc./
08:16pm, Thursday, 31'st Oct 2019
In a release issued under the same headline on October 29th by Curis, Inc., please note that in the first and second paragraphs of the release, financial results will be reported before Nasdaq market
Curis (CRIS) Presents At Cantor Healthcare Conference - Slideshow
12:00am, Thursday, 03'rd Oct 2019NEO's strategy of 'pragmatic' centralization
07:27pm, Monday, 30'th Sep 2019
One of NEO’s competitive advantages over Bitcoin and Ethereum is its ‘pragmatic’ approach toward centralization, argues founder Da Hongfei.
